Royal college

ATA Creativity Global Reports First Quarter 2024 Financial Results

Retrieved on: 
火曜日, 5月 14, 2024
AACG, University of Pennsylvania, UNESCO, University, Sustainable Development Goals, Liberal arts college, Visual communication, Royal college, Photography, Bangladesh Technical Education Board, Master, United, Growth, Pratt Institute, School, Student, ACG, United Nations University, Cornell University, United Nations, Harvard University, Creativity

BEIJING, May 14, 2024 (GLOBE NEWSWIRE) -- ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today announced preliminary unaudited financial results for the quarter ended March 31, 2024 (“First Quarter 2024”).

Key Points: 
  • BEIJING, May 14, 2024 (GLOBE NEWSWIRE) -- ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today announced preliminary unaudited financial results for the quarter ended March 31, 2024 (“First Quarter 2024”).
  • During First Quarter 2024, student enrollment was 1,370, an increase of 24.9% from 1,097 in the prior-year period.
  • 33,527 credit hours were delivered during First Quarter 2024, an increase of 21.3% from 27,630 in the prior-year period.
  • First Quarter 2024 net loss attributable to ACG of RMB17.9 million (US$2.5 million), compared to RMB17.8 million in the prior-year period.

The Inner Circle Acknowledges, Divyakant B. Gandhi, MBBS, FRCS, FACS, Circle as a Distinguished Cardiothoracic Surgeon

Retrieved on: 
月曜日, 5月 6, 2024
Doctor of Philosophy, Education, Atrial fibrillation, Cardiothoracic surgery, American College, Multimedia, Lung cancer, MBBS, Coronary artery disease, Mentorship, Ohio State University, Ventricular septal defect, Elective surgery, Heart, Parent, Research, University, FACS, Multiple, Lung, Inner circle, McLaren Health Care Corporation, Patient, Medicine, Circulatory system, Physician, Intellectual property, Health, Mitral valve, FRCS, Student, General surgery, Quality of life, Georgia Tech, Medical college, Royal, Royal college

Divyakant B. Gandhi is an international physician, innovative thinker, and leader in cardiac care.

Key Points: 
  • Divyakant B. Gandhi is an international physician, innovative thinker, and leader in cardiac care.
  • He has been in practice as a Heart, Lung & Vascular surgeon for over 35 years.
  • As a leader in the clinical setting, Dr. Gandhi is the Chief of Staff, Medical Director, and Chief of Cardiovascular & Thoracic Surgery at McLaren Greater Lansing.
  • Dr. Gandhi practices his specialty under the auspices of the Center for Cardiovascular and Thoracic Surgery in Detroit, MI.

Olive Fertility Centre Victoria Welcomes New Fertility Specialist Dr. Riki Dayan

Retrieved on: 
月曜日, 5月 6, 2024
Olive, Education, Physician, University, Regius Professor, UBC, Air pollution, Pregnancy, McMaster University, Fertility, Research, Gynaecology, IVF, Family, Patient, Mindfulness, Surgeon, Multimedia, Meditation, Royal college, Medical device

VICTORIA, BC, May 6, 2024 /PRNewswire-PRWeb/ -- Olive Fertility Centre is pleased to announce that Dr. Riki Dayan MD FRCSC has joined the Olive Fertility Victoria Team. "We are delighted to welcome Dr. Dayan to Olive Fertility," says Olive co-director Dr. Niamh Talon. "With her expertise in fertility, her dedication to education and her focus on whole person, patient-centred care, Dr. Dayan is an invaluable addition to the Olive Team."

Key Points: 
  • Olive Fertility Centre is pleased to announce that Dr. Riki Dayan MD FRCSC has joined the Olive Fertility Victoria Team.
  • VICTORIA, BC, May 6, 2024 /PRNewswire-PRWeb/ -- Olive Fertility Centre is pleased to announce that Dr. Riki Dayan MD FRCSC has joined the Olive Fertility Victoria Team.
  • "We are delighted to welcome Dr. Dayan to Olive Fertility," says Olive co-director Dr. Niamh Talon.
  • "With her expertise in fertility, her dedication to education and her focus on whole person, patient-centred care, Dr. Dayan is an invaluable addition to the Olive Team."

DR. KIYA MOVASSAGHI ASSUMES PRESIDENCY OF THE AESTHETIC SOCIETY, CHARTING A COURSE FOR GLOBAL PARTNERSHIPS AND ADVANCING AESTHETIC EDUCATION

Retrieved on: 
日曜日, 5月 5, 2024
Education, General surgery, Breast, Resident, Weight loss, Partnership, NYU, University, Face, Rhinoplasty, Woman, DMD, Large, Abdominoplasty, Navy, Executive Committee, Memorandum, Mount Sinai Hospital, Harvard Medical School, Fifth Avenue, Emory University, Royal college, Microsoft, Safety, Publication, Plastic surgery, Division, The Hamptons, School, Society, Patient, Medical school, University Health Network, Elective surgery, FACS, Annual general meeting, Massachusetts General Hospital, Women's College Hospital, Dentistry

VANCOUVER, BC, May 5, 2024 /PRNewswire/ -- The Aesthetic Society proudly announces the appointment of Dr. Kiya Movassaghi, a board-certified plastic surgeon from Eugene, OR, as the President of The Aesthetic Society. Dr. Movassaghi's leadership will focus on strategically fortifying The Society's position as the global leader in education and innovation in the aesthetic marketplace.

Key Points: 
  • Dr. Movassaghi's leadership will focus on strategically fortifying The Society's position as the global leader in education and innovation in the aesthetic marketplace.
  • "I am honored to assume the presidency of The Aesthetic Society," said Dr. Movassaghi.
  • Global outreach through Memorandums of Understanding (MOUs) will be instrumental in shaping our engagement and alliances among our international colleagues.
  • A 1995 graduate of Harvard Medical School, Dr. Movassaghi completed a three-year plastic surgery residency at the Harvard Combined Plastic Surgery Program.

New Transformative Leadership Team Announced for Texas Children's World-Renowned Heart Center

Retrieved on: 
金曜日, 5月 3, 2024
News, Pediatrics, Surgeon, Doctor of Philosophy, Bachelor of Science, Baylor University, Diagnosis, Texas Children's Hospital, Medical director, University, DRS, Ventricular septal defect, Baylor College of Medicine, Faculty, Moss, Royal Children, National university, Royal college, Executive, Hospital, Research, Monash University, Division, Congenital heart defect, Arrhythmia, Cardiomyopathy, NHS foundation trust, Evelina London Children's Hospital, Patient, Principal, Molecular medicine, Growth, Dentistry

Dr. Daniel Penny , previously Chief of Cardiology at Texas Children's Hospital, was recently named as Executive Co-Director of the Heart Center.

Key Points: 
  • Dr. Daniel Penny , previously Chief of Cardiology at Texas Children's Hospital, was recently named as Executive Co-Director of the Heart Center.
  • "We are incredibly proud to announce our new Heart Center executive leadership team," said Dr. Lara Shekerdemian , Pediatrician-In-Chief and chair of Pediatrics at Texas Children's Hospital.
  • "I am truly honored to join the leadership team at Texas Children's Heart Center," said Dr. Salih.
  • "For many decades now, Texas Children's Heart Center has cared for the world's rarest and most complex heart conditions.

joimax® Obtains Registration for All Products in the Indian Market

Retrieved on: 
木曜日, 4月 25, 2024
Surgery, Health, Medical Devices, Education, Multimedia, MDR, Patient, Royal college, Hospital

View the full release here: https://www.businesswire.com/news/home/20240425620967/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240425620967/en/
    The three pillars of the joimax® spinal therapy program.
  • (Graphic: Business Wire)
    The Indian registration includes all joimax® Class II and III, as well as Class I instruments, which were approved in 2023.
  • Now, the Indian health community has access to all the latest spinal endoscopic technologies invented, developed and manufactured by joimax®.
  • The program allows for the highest quality training of joimax® products in any market, serving as a hands-on learning facility for endoscopic spinal surgery.

LEXUS PRESENTS "TIME" AT THE 2024 MILAN DESIGN WEEK

Retrieved on: 
月曜日, 4月 15, 2024
Midnight, SIHH, System, Product design, University of Tokyo, Death, New National Theatre Tokyo, Postgraduate education, Life, Singing, Tree, Horizon, Music award, Android, OPV, Exhibition, COS, Software, EV, Research institute, Absolute music, Aerospace engineering, Design, Tangent, Milan Furniture Fair, Bev, Royal college, Power station, Solar energy, Transport, Carbon, Engineering, Light, Japanese Movie Critics Awards, Organic solar cell, Swarovski, University, Glass, BEV, Liberal arts college, History, Calligraphy Greenway, Superstudio, Advanced Art, Sound, Renewable energy

MILAN, April 15, 2024 /PRNewswire/ -- Lexus has unveiled its installation Time at the world's largest design event, Milan Design Week, in Milan, Italy. Located in Art Point and Art Garden at the Superstudio Più in the Tortona design district, a hub for global creative convergence, the exhibit is open until April 21, 2024.

Key Points: 
  • MILAN, April 15, 2024 /PRNewswire/ -- Lexus has unveiled its installation Time at the world's largest design event, Milan Design Week, in Milan, Italy.
  • It also expresses Lexus' resolve to redefine luxury in synergy with carbon neutrality, exploring how energy and software can advance mobility innovation.
  • At Art Point, Hideki Yoshimoto/Tangent presents Beyond the Horizon, expressing a world of next-generation mobility that evolves infinitely through software.
  • Furthermore, she was appointed as an ambassador for the Dutch Design Week in 2022, enhancing her commitment to solar energy.

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

Retrieved on: 
火曜日, 4月 2, 2024
Patient, MIB, ARI, Therapy, AAO, Research, Surgeon, Thomas Jefferson University, German Research Foundation, Chairperson, American Diabetes Association, Macular degeneration, SAB, FACS, Food, Cornell University, Empire, University, Castle Connolly Medical, Laborie (company), Publication, Emerita, AMD, FDA, Cochrane (organisation), Moorfields Eye Hospital, American Academy, Most, Consultant, Physician, Royal college, Diabetic retinopathy, Commander, Pharmaceutical industry

WATERTOWN, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced the appointment of leading global ophthalmologists to its Scientific Advisory Board (SAB), co-chaired by Carl Regillo M.D., FACS, Chief of the Retina Service at Wills Eye Hospital and Charles Wykoff, M.D., Ph.D., Director of Research of Retina Consultants of Texas. The SAB additions include Usha Chakravarthy, M.B.B.S., Ph.D.; Allen Ho, M.D. FACS FASRS, and Frank Holz, M.D., F.E.B.O., F.A.R.V.O. These three world-renowned retinal specialists will support advancement of the Company’s global clinical strategy ahead of the anticipated initiation of its Phase 3 pivotal trials in wet age-related macular degeneration (wet AMD) in the second half of this year. Additionally, the Company announced that the U.S. Food and Drug Administration (FDA) has conditionally accepted the trade name, DURAVYUTM (vorolanib intravitreal insert) for the Company’s lead product candidate, EYP-1901.

Key Points: 
  • “The SAB’s strategic counsel, global expertise, and scientific knowledge will be incredibly valuable during this critical time in EyePoint’s growth and expansion.
  • Dr. Chakravarthy has authored or co-authored over 400 publications, and she is invited to lecture in the UK and abroad.
  • FACS FASRS is Attending Surgeon, Director of Retina Research and Co-Director of the Retina Service of Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.
  • He is a Board Member of the German Ophthalmological Society, and of the Club Jules Gonin and is past president of EURETINA.

Autolus Therapeutics Announces Changes to its Board of Directors

Retrieved on: 
月曜日, 4月 1, 2024
Cubist Pharmaceuticals, DBV Technologies, MB, Alnylam Pharmaceuticals, Harvard Medical School, University of Cambridge, Faculty, Imperial College London, Development, GSK plc, Biologics license application, Hematology, Patient, ALL, Merck, Bristol Myers Squibb, Marketing, Biogen, Doctor of Philosophy, Bates College, Oxford Biomedica, Sarepta Therapeutics, Pharmaceutical medicine, Therapy, Swedish Orphan Biovitrum, Royal college, FDA, BLA, Autoimmunity, Economics, Food, Pharmaceutical industry

John H. Johnson advised the Board of his decision to step down from his role as Chairman of the Board and Non-Executive Director.

Key Points: 
  • John H. Johnson advised the Board of his decision to step down from his role as Chairman of the Board and Non-Executive Director.
  • We wish John much success with his new projects,” said Dr. Christian Itin, Chief Executive Officer of Autolus.
  • He is currently a director of Alnylam Pharmaceuticals and chair of Dunad Therapeutics and Gulf of Maine Research Institute.
  • Mr. Bonney has served as a director with many companies previously including Celgene, Kaleido Biosciences, Magenta Therapeutics, Bristol Myers Squibb, Sarepta Therapeutics and Syros Pharmaceuticals.

The Aesthetic Society Urges Immediate Action: Stronger Regulations of Outpatient Aesthetic Surgery in California and Across the United States

Retrieved on: 
金曜日, 4月 5, 2024
Hospital, Abdominal ultrasonography, Medicine, Surgeon, Plastic, ABPS, Risk, Education, Patient, Dermatology, Plastic surgery, Death, Continuing medical education, CSPS, ASC, ABMS, Safety, Physician, Royal college, Patient safety, Dentistry

This article explores an alarming lack of regulation for physicians performing outpatient aesthetic surgeries in California.

Key Points: 
  • This article explores an alarming lack of regulation for physicians performing outpatient aesthetic surgeries in California.
  • Dr. Melinda Haws, President of The Aesthetic Society, emphasized the importance of patient safety and the need for stringent regulations in aesthetic medicine.
  • All members of The Aesthetic Society and The California Society of Plastic Surgeons are ABPS board-certified.
  • As a professional body, The Aesthetic Society is dedicated to advocating for patient safety and upholding the highest standards of care in the field of aesthetic surgery.